Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/FCF ratio high or low?
The Price/FCF ratio of 0.55 is 25% below its estimated 1-year average of 0.74, near the low end of its estimated 1-year range (0.55–0.91).
As of 2026-10-06T15:41:49.560Z.
Calculation as of: 2026-10-06T15:41:49.560Z.
Quote observation: 2026-10-06T15:40:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9199062e3d99303b6ceeba444dd11ff94fafae694fd5228a7a2e61ab73072144
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
0.55
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
21.43
median of 181 covered companies
CURRENT VS SECTOR MEDIAN
-97.43%
vs the sector median at left
Market Cap
$69.26M
Price/FCF Ratio
N/A
TTM Avg
17.09
3Y Avg
24.44
5Y Avg
36.17
Market Cap
$70.95M
Price/FCF Ratio
N/A
TTM Avg
1291.26
3Y Avg
1291.26
5Y Avg
1291.26
Market Cap
$63.98M
Price/FCF Ratio
N/A
TTM Avg
1.90
3Y Avg
1.90
5Y Avg
1.90
Market Cap
$63.78M
Price/FCF Ratio
N/A
TTM Avg
47.92
3Y Avg
47.92
5Y Avg
47.92
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $69.03M | 0.55 | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $67.20M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $69.26M | N/A | 17.09 | 24.44 | 36.17 |
| MindWalk Holdings Corp. (HYFT)vs › | $70.95M | N/A | 1291.26 | 1291.26 | 1291.26 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | 35.77 | 35.77 | 35.77 |
| Cingulate Inc. (CING)vs › | $65.86M | N/A | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $74.41M | N/A | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.98M | N/A | 1.90 | 1.90 | 1.90 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A | 47.92 | 47.92 | 47.92 |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | N/A | N/A | N/A | N/A |
P/FCF Ratio
0.6
FCF Yield
182.31%
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-10-05 | 0.61 |
| 2026-10-02 | 0.60 |
| 2026-10-01 | 0.61 |
| 2026-09-30 | 0.63 |
| 2026-09-29 | 0.65 |
| 2026-09-28 | 0.64 |
| 2026-09-25 | 0.67 |
| 2026-09-24 | 0.67 |
| 2026-09-23 | 0.69 |
| 2026-09-22 | 0.72 |
| 2026-09-21 | 0.71 |
| 2026-09-18 | 0.74 |
| 2026-09-17 | 0.74 |
| 2026-09-16 | 0.72 |
| 2026-09-15 | 0.73 |
| 2026-09-14 | 0.74 |
| 2026-09-11 | 0.74 |
| 2026-09-10 | 0.76 |
| 2026-09-09 | 0.77 |
| 2026-09-08 | 0.80 |
| 2026-09-04 | 0.80 |
| 2026-09-03 | 0.80 |
| 2026-09-02 | 0.80 |
| 2026-09-01 | 0.79 |
| 2026-08-31 | 0.81 |
| 2026-08-28 | 0.81 |
| 2026-08-27 | 0.82 |
| 2026-08-26 | 0.83 |
| 2026-08-25 | 0.83 |
| 2026-08-24 | 0.86 |
| 2026-08-21 | 0.84 |
| 2026-08-20 | 0.81 |
| 2026-08-19 | 0.84 |
| 2026-08-18 | 0.86 |
| 2026-08-17 | 0.83 |
| 2026-08-14 | 0.86 |
| 2026-08-13 | 0.73 |
| 2026-08-12 | 0.67 |
| 2026-08-11 | 0.64 |
| 2026-08-10 | 0.67 |
| 2026-08-07 | 0.65 |
| 2026-08-06 | 0.67 |
| 2026-08-05 | 0.68 |
| 2026-08-04 | 0.66 |
| 2026-08-03 | 0.67 |
| 2026-07-31 | 0.76 |
| 2026-07-30 | 0.80 |
| 2026-07-29 | 0.82 |
| 2026-07-28 | 0.83 |
| 2026-07-27 | 0.80 |
| 2026-07-24 | 0.81 |
| 2026-07-23 | 0.84 |
| 2026-07-22 | 0.87 |
| 2026-07-21 | 0.86 |
| 2026-07-20 | 0.81 |
| 2026-07-17 | 0.82 |
| 2026-07-16 | 0.83 |
| 2026-07-15 | 0.90 |
| 2026-07-14 | 0.91 |
| 2026-07-13 | 0.80 |
| 2026-07-10 | 0.80 |
| 2026-07-09 | 0.80 |
| 2026-07-08 | 0.73 |
| 2026-07-07 | 0.73 |
| 2026-07-06 | 0.72 |
| 2026-07-02 | 0.74 |
| 2026-07-01 | 0.75 |
| 2026-06-30 | 0.75 |
| 2026-06-29 | 0.72 |
| 2026-06-26 | 0.67 |
| 2026-06-25 | 0.74 |
| 2026-06-24 | 0.77 |
| 2026-06-23 | 0.77 |
| 2026-06-22 | 0.75 |
| 2026-06-18 | 0.73 |
| 2026-06-17 | 0.75 |
| 2026-06-16 | 0.71 |
| 2026-06-15 | 0.70 |
| 2026-06-12 | 0.67 |
| 2026-06-11 | 0.67 |
| 2026-06-10 | 0.67 |
| 2026-06-09 | 0.71 |
| 2026-06-08 | 0.69 |
| 2026-06-05 | 0.65 |
| 2026-06-04 | 0.67 |
| 2026-06-03 | 0.64 |
| 2026-06-02 | 0.65 |
| 2026-06-01 | 0.63 |
| 2026-05-29 | 0.68 |
| 2026-05-28 | 0.68 |
| 2026-05-27 | 0.67 |
| 2026-05-26 | 0.66 |
| 2026-05-22 | 0.67 |
| 2026-05-21 | 0.68 |
| 2026-05-20 | 0.65 |
| 2026-05-19 | 0.62 |
| 2026-05-18 | 0.60 |
| 2026-05-15 | 0.59 |
